PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.

Mass population testing for prostate cancer will not see men proactively invited for the PSA blood test - here is all you need to know about who can get checked ...

We have made important advancements in treatment, but are still being overwhelmed by the number of late-stage cases ...

The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

When it comes to prostate cancer, there’s a lot of confusion and guesswork floating around—especially among men who don’t ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as ...

The IsoPSA test is intended to help assess whether patients with elevated PSA levels should go on to receive a biopsy ...

Prostate cancer is one of the most common cancers affecting men, especially over the age of 50. As per the American Cancer ...

Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.